Genus Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Genus de 26% y 4.5% por año respectivamente. Se prevé que el BPA crezca en un 27.8% al año. Se espera que la rentabilidad financiera sea de 10.4% en 3 años.

Información clave

26.0%

Tasa de crecimiento de los beneficios

27.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Biotechs	28.5%
Tasa de crecimiento de los ingresos	4.4%
Rentabilidad financiera futura	10.4%
Cobertura de analistas	Low
Última actualización	29 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Nov 17

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Oct 25

Genus (LON:GNS) Is Paying Out A Dividend Of £0.217

Oct 11

Genus' (LON:GNS) Dividend Will Be £0.217

Sep 11

A Look At The Fair Value Of Genus plc (LON:GNS)

Sep 09

A Look At The Intrinsic Value Of Genus plc (LON:GNS)

May 31

Is Genus (LON:GNS) A Risky Investment?

Mar 29

Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10

Feb 27

Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 22

With EPS Growth And More, Genus (LON:GNS) Is Interesting

Oct 29

Here's Why Genus (LON:GNS) Can Manage Its Debt Responsibly

Oct 14

Genus (LON:GNS) Could Easily Take On More Debt

Apr 05

Is Genus' (LON:GNS) 235% Share Price Increase Well Justified?

Mar 18

Trade Alert: The Independent Non-Executive Chairman Of Genus plc (LON:GNS), Iain G. Ferguson, Has Just Spent UK£73k Buying 150% More Shares

Feb 28

I Ran A Stock Scan For Earnings Growth And Genus (LON:GNS) Passed With Ease

Feb 26

How Much Of Genus plc (LON:GNS) Do Institutions Own?

Feb 01

Genus plc (LON:GNS) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Dec 22

Have Genus plc (LON:GNS) Insiders Been Selling Their Stock?

Dec 05

Is Genus' (LON:GNS) Share Price Gain Of 195% Well Earned?

Nov 20

Previsiones de crecimiento de beneficios e ingresos

LSE:GNS - Estimaciones futuras de los analistas y datos financieros pasados (GBP Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2026	746	54	58	82	4
6/30/2025	711	43	57	84	5
6/30/2024	674	25	20	48	5
12/31/2023	673	33	10	45	N/A
9/30/2023	681	33	13	48	N/A
6/30/2023	690	33	15	50	N/A
3/31/2023	676	34	-1	42	N/A
12/31/2022	662	34	-18	35	N/A
9/30/2022	628	38	-25	34	N/A
6/30/2022	593	41	-31	34	N/A
3/31/2022	582	39	-20	39	N/A
12/31/2021	570	37	-9	43	N/A
9/30/2021	572	42	13	55	N/A
6/30/2021	574	47	34	68	N/A
3/31/2021	570	45	42	70	N/A
12/31/2020	566	42	50	72	N/A
9/30/2020	559	39	40	66	N/A
6/30/2020	551	35	30	60	N/A
3/31/2020	536	37	25	55	N/A
12/31/2019	520	39	19	49	N/A
9/30/2019	504	23	12	41	N/A
6/30/2019	489	8	5	33	N/A
3/31/2019	480	1	6	35	N/A
12/31/2018	471	-7	7	37	N/A
9/30/2018	470	18	14	40	N/A
6/30/2018	470	43	21	43	N/A
3/31/2018	473	55	23	42	N/A
12/31/2017	476	67	25	41	N/A
9/30/2017	467	50	N/A	38	N/A
6/30/2017	459	33	N/A	35	N/A
3/31/2017	441	40	N/A	34	N/A
12/31/2016	422	47	N/A	33	N/A
9/30/2016	405	48	N/A	31	N/A
6/30/2016	388	49	N/A	30	N/A
3/31/2016	388	40	N/A	25	N/A
12/31/2015	388	31	N/A	21	N/A
9/30/2015	393	35	N/A	28	N/A
6/30/2015	399	40	N/A	35	N/A
3/31/2015	394	36	N/A	38	N/A
12/31/2014	389	32	N/A	41	N/A
9/30/2014	381	30	N/A	37	N/A
6/30/2014	372	29	N/A	32	N/A
3/31/2014	366	27	N/A	33	N/A
12/31/2013	360	25	N/A	34	N/A
9/30/2013	353	24	N/A	29	N/A
6/30/2013	345	23	N/A	24	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (26% al año) de GNS es superior a la tasa de ahorro (1.6%).

Beneficios vs. Mercado: Se prevé que los beneficios (26% al año) de GNS crezcan más rápidamente que el mercado UK (12.2% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de GNS crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (4.5% al año) de GNS crezcan más rápidamente que los del mercado UK (3.4% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 4.5% al año) de GNS crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de GNS sea baja dentro de 3 años (10.4%).

Genus Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 7.9% to UK£28.74

Price target decreased by 10% to UK£29.62

Consensus EPS estimates fall by 23%

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Consensus EPS estimates fall by 19%

Recent updates

Price target decreased by 7.9% to UK£28.74

Estimating The Fair Value Of Genus plc (LON:GNS)

Is Genus (LON:GNS) Using Too Much Debt?

With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For

Investor sentiment deteriorates as stock falls 15%

Price target decreased by 10% to UK£29.62

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103

First half dividend of UK£0.10 announced

First half 2024 earnings released: EPS: UK£0.21 (vs UK£0.20 in 1H 2023)

Consensus EPS estimates fall by 23%

Investor sentiment deteriorates as stock falls 19%

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Genus plc Provides Earnings Guidance for the First Half of Fiscal 2024

Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult

Genus Appoints Ralph Heuser as Non-Executive Director, with effect from 1 January 2024

Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?

Genus plc to Report Fiscal Year 2024 Results on Sep 05, 2024

Genus plc Approves to Declare Final Dividend

We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt

Upcoming dividend of UK£0.22 per share at 1.4% yield

Full year 2023 earnings: EPS exceeds analyst expectations

Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs

Colombian Government Gives Positive Determination for Genus's PRRS Virus-Resistant Pigs

Executive Director exercised options and sold UK£194k worth of stock

Consensus EPS estimates fall by 19%

Calculating The Intrinsic Value Of Genus plc (LON:GNS)

Full year 2023 earnings: EPS exceeds analyst expectations

Genus plc Announces Lykele Van Der Broek to Step Down from the Genus Board

AB Agri Ltd. completed the acquisition of National Milk Records plc (OFEX:NMRP) from Livestock Improvement Corporation Limited (NZSE:LIC), ICM Investment Management Limited, Genus plc (LSE:GNS), Custodial Capital Management Limited, High Street Partners, Ltd, and Working Capital Partners Ltd.

Price target decreased by 8.4% to UK£38.82

Now 20% undervalued after recent price drop

Price target decreased by 8.0% to UK£40.28

Is Genus (LON:GNS) A Risky Investment?

First half 2023 earnings released: EPS: UK£0.20 (vs UK£0.30 in 1H 2022)

Is Genus (LON:GNS) Using Too Much Debt?

Price target decreased to UK£40.14

Genus plc to Report Fiscal Year 2023 Results on Sep 07, 2023

It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Investor sentiment improved over the past week

Upcoming dividend of UK£0.22 per share

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Genus (LON:GNS) Is Paying Out A Dividend Of £0.217

Genus' (LON:GNS) Dividend Will Be £0.217

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

A Look At The Fair Value Of Genus plc (LON:GNS)

Investor sentiment improved over the past week

Genus plc Proposes Final Dividend, Payable on 9 December 2022

Investor sentiment improved over the past week

A Look At The Intrinsic Value Of Genus plc (LON:GNS)

Price target decreased to UK£46.05

Is Genus (LON:GNS) A Risky Investment?

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10

Genus plc Proposes Interim Dividend, Payable on March 31, 2022

Genus plc to Report First Half, 2022 Results on Feb 24, 2022

Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value

Independent Non-Executive Chairman recently bought UK£224k worth of stock

Upcoming dividend of UK£0.22 per share

With EPS Growth And More, Genus (LON:GNS) Is Interesting

Full year 2021 earnings released: EPS UK£0.73 (vs UK£0.54 in FY 2020)

Chief Operating Officer recently sold UK£336k worth of stock

Here's Why Genus (LON:GNS) Can Manage Its Debt Responsibly

Insider recently sold UK£1.4m worth of stock

Full year 2021 earnings released: EPS UK£0.73 (vs UK£0.62 in FY 2020)

Genus plc (LSE:GNS) acquired Trade and assets of Sergal Gestio Ramadera, S.L. from Sergal Gestio Ramadera Sl for £7.7 million.

Independent Non-Executive Director Ian Charles has left the company

Genus (LON:GNS) Could Easily Take On More Debt

Independent Non-Executive Chairman recently bought UK£72k worth of stock

Is Genus' (LON:GNS) 235% Share Price Increase Well Justified?